Riskpilot← Back to searchSign inGet full accessCardioran AB
ABActiveOrg 5590680905Grevgatan 4 NbMedical specialists activities · NACE 8622Est. 20162 employees
Revenue 2025
SEK 3,2M
+10% vs 2024
EBITDA margin
40.6%
+34% vs 2024
Equity ratio
89.7%
Financial strength
Net profit 2025
SEK 995K
+35% vs 2024
| Revenue | SEK 3,2M | +10% |
| EBITDA | SEK 1,3M | +34% |
| Net profit | SEK 995K | +35% |
| Total assets | SEK 2,4M | +20% |
| Equity | SEK 2,1M | +23% |
| Employees | 2 | — |
Legal name
Cardioran AB
Org number
5590680905
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
30 juni 2016
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriva specialistsjukvård samt hälsovård ej på sjukhus samt förvaltning av värdepapper.
Address
Grevgatan 4 Nb
Email
eva-marie.rane@hlamottagningen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 299 | 2 838 | 3 027 | 2 918 | 3 218 |
| Staff expenses | — | −1 064 | −1 058 | −1 138 | −1 051 |
| EBITDA | 1 031 | 1 162 | 1 225 | 977 | 1 307 |
| Depreciation & amort. | −7 | −18 | −20 | −47 | −50 |
| EBIT | 1 024 | 1 144 | 1 205 | 931 | 1 257 |
| Net financials | −1 | −1 | −0 | 0 | −1 |
| Profit before tax | 1 024 | 1 144 | 1 205 | 931 | 1 256 |
| Tax | −218 | −239 | −251 | −194 | −262 |
| Net profit | 806 | 905 | 954 | 736 | 995 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 081 | 1 204 | 1 796 | 1 977 | 2 374 |
| Equity | 839 | 1 044 | 1 498 | 1 734 | 2 129 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 242 | 160 | 298 | 243 | 245 |
| Total debt | 242 | 160 | 298 | 243 | 245 |
EBITDA margin
40.6%
This company
15.8%
Market median
+157% vs market
20212025
Equity ratio
89.7%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
46.7%
This company
18.4%
Market median
+154% vs market
20212025
Net profit margin
30.9%
This company
8.1%
Market median
+281% vs market
20212025
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2022 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cardioran AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Olof Anders Johansson Sjödin | Audit | 0 companies |
| Clary Adela Johansson | Deputy Board Member | 0 companies |
| Eva-Marie Rane | Board of Directors | 0 companies |
| Philip August Andreas Rane | Deputy Board Member | 0 companies |